Effective May 11, 2020, the Board of Directors of BioDelivery Sciences International, Inc. (the “Company”) appointed Jeffrey Bailey as the Company's Interim Chief Executive Officer. Mr. Bailey joined the Company in March 2020 as a member of the Board. Mr. Bailey has served as Chair of the Board of Directors of Aileron Therapeutics, a biotechnology company, since March 2018.

From January 2018 to April 2020, Mr. Bailey served as Chief Executive Officer and Director of IlluminOss Medical, Inc. Mr. Bailey has also served as a Director of Madison Vaccines, Inc., since October 2017. From December 2015 to March 2017, Mr. Bailey served as Chair and Chief Executive Officer of Neurovance, Inc. From January 2013 to June 2015, Mr. Bailey served as President and Chief Executive Officer and as a Director of Lantheus Medical Imaging, Inc. On May 11, 2020, the Company also announced that Herm Cukier was terminated without cause as Chief Executive Officer and principal executive officer, effective as of May 9, 2020. In connection with his termination, Mr. Cukier also resigned from the Board of Directors, effective as of May 9, 2020.